Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings

Prospective, Multi-country, Non-Interventional Study to Investigate REKOVELLE for Ovarian Stimulation: the Effectiveness, Safety, and Patterns Of Use for Asian Women in Real World Practice

Primary objective is to investigate the effectiveness of REKOVELLE® in women undergoing their first REKOVELLE® ovarian stimulation treatment in real world practice in Asian countries.

Inclusion Criteria:

• Females aged 20 years or older at enrollment
• Serum AMH level >0.5 ng / mL (with the latest result tested within 12 months)
• Who are first time prescribed REKOVELLE for their ovarian stimulation and IVF or ICSI treatment cycle using fresh or frozen ejaculated sperm from male partner or sperm donor (if applicable)
• Willing and able to provide written informed consent

Exclusion Criteria:

• Have undergone more than 2 COS-IVF / ICSI cycles before the enrollment
• Participating in an interventional clinical trial in which any medication treatment is mandated
• Women with a contraindication for prescription of REKOVELLE treatment
• Oocyte donors
• Undergoing ovarian stimulation for fertility preservation